iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/38638251/
Unilateral branch retinal artery occlusion in association with COVID-19: a case report - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 18;17(4):777-782.
doi: 10.18240/ijo.2024.04.25. eCollection 2024.

Unilateral branch retinal artery occlusion in association with COVID-19: a case report

Affiliations

Unilateral branch retinal artery occlusion in association with COVID-19: a case report

Kunihiko Hirosawa et al. Int J Ophthalmol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Inomata T, reports non-financial support from Lion Corporation and Sony Network Communications Inc., grants from Johnson & Johnson Vision Care, Inc., Kandenko, Co., Ltd., Yuimedi, Inc., Rohto Pharmaceutical Co., Ltd., Kobayashi Pharmaceutical Co., Ltd., Kandenko Co., Ltd., and Fukoku Co., Ltd., personal fees from Santen Pharmaceutical Co., Ltd., InnoJin, Inc., and Ono Pharmaceutical Co., Ltd., outside the submitted work; Okumura Y and Nagino K, report personal fees from InnoJin, Inc., outside the submitted work; Nakao S, reports grants from Kowa Company. Ltd., Mitsubishi Tanabe Pharma Corporation, Alcon Japan, Ltd., Santen Pharmaceutical Co., Ltd., Machida Endoscope Co., Ltd., Wakamoto Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Senju Pharmaceutical Co., Ltd. Nippon Boehringer Ingelheim Co., Ltd., Chugai Pharmaceutical Co., Ltd., Hoya Corporation, and Novartis Pharma K.K., outside the submitted work; Hirosawa K, None; Sung J, None; Morooka Y, None; Huang T, None; Akasaki Y, None; Omori K, None.

Figures

Figure 1
Figure 1. Findings of right retina at first time
A: Fundus photograph showing retinal whitening in the superior macular hemisphere. B: Fluorescein angiography indicating delayed filling in the superior macular branch artery (red arrow). C: Optical coherence tomography showing hyperintense reflection and thickening of the inner retinal layer.
Figure 2
Figure 2. Findings of right visual field at the initial consultation
Goldmann perimeter test showing a central lower visual field defect on the right eye.
Figure 3
Figure 3. Findings at 6mo follow-up
A: Optical coherence tomography showing the retinal inner layer thinning in areas consistent with retinal ischemia. B: Humphrey field analyzer showing the central lower visual field defect.

Similar articles

References

    1. Biousse V, Nahab F, Newman NJ. Management of acute retinal ischemia: follow the guidelines! Ophthalmology. 2018;125(10):1597–1607. - PubMed
    1. Scott IU, Campochiaro PA, Newman NJ, Biousse V. Retinal vascular occlusions. Lancet. 2020;396(10266):1927–1940. - PMC - PubMed
    1. Kahloun R, Mbarek S, Khairallah-Ksiaa I, Jelliti B, Yahia SB, Khairallah M. Branch retinal artery occlusion associated with posterior uveitis. J Ophthalmic Inflamm Infect. 2013;3(1):16. - PMC - PubMed
    1. Lang GE, Spraul CW. Risk factors for retinal occlusive diseases. Klin Monbl Augenheilkd. 1997;211(4):217–226. - PubMed
    1. Feltgen N, Pielen A. Retinal artery occlusion. Ophthalmologe. 2017;114(2):177–190. - PubMed

LinkOut - more resources